Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 13651-13700 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04285086
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
PHASE3Active, not recruiting
174 participants
Started: Aug 25, 2020 · Completed: Aug 31, 2029
1 condition1 sponsor65 locations
NCT04498117
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
PHASE3Active, not recruiting
615 participants
Started: Aug 25, 2020 · Completed: Aug 26, 2028
10 conditions3 sponsors148 locations
NCT04522271
Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)
NAActive, not recruiting
80 participants
Started: Aug 25, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04511962
Feasibility, of Tele-rehabilitation Following COVID-19
N/AActive, not recruiting
40 participants
Started: Aug 24, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04403295
Collaborative Specialty Care for Gulf War Illness
NAActive, not recruiting
281 participants
Started: Aug 24, 2020 · Completed: May 29, 2026
1 condition1 sponsor1 location
NCT04541563
Fisher Wallace Neurostimulation & Depression Study
NAActive, not recruiting
175 participants
Started: Aug 24, 2020 · Completed: Nov 30, 2021
1 condition2 sponsors1 location
NCT04329429
A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer
PHASE2Active, not recruiting
57 participants
Started: Aug 24, 2020 · Completed: Jun 30, 2024
1 condition1 sponsor16 locations
NCT04165564
DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers
N/AActive, not recruiting
85 participants
Started: Aug 24, 2020 · Completed: Dec 31, 2026
1 condition3 sponsors19 locations
NCT03814356
Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness
PHASE1Active, not recruiting
10 participants
Started: Aug 24, 2020 · Completed: Aug 1, 2025
4 conditions1 sponsor1 location
NCT04502602
Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer
PHASE1Active, not recruiting
18 participants
Started: Aug 24, 2020 · Completed: May 31, 2029
2 conditions3 sponsors1 location
NCT04435288
Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade
PHASE3Active, not recruiting
90 participants
Started: Aug 24, 2020 · Completed: Dec 31, 2028
1 condition2 sponsors6 locations
NCT04454957
Mastering Diabetes Study
NAActive, not recruiting
100 participants
Started: Aug 24, 2020 · Completed: Jun 30, 2025
2 conditions2 sponsors1 location
NCT04364854
Speech Entrainment for Aphasia Recovery
PHASE2Active, not recruiting
80 participants
Started: Aug 21, 2020 · Completed: Oct 1, 2025
3 conditions2 sponsors3 locations
NCT04408833
Palmitate Study: A Method Study of Dietary Lipid Oxidation in Toddlers
N/AActive, not recruiting
10 participants
Started: Aug 21, 2020 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT04300855
Clinical Trial of Green Tea Catechins in Men on Active Surveillance
PHASE2Active, not recruiting
115 participants
Started: Aug 21, 2020 · Completed: Feb 27, 2027
2 conditions2 sponsors2 locations
NCT04479267
Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma
PHASE2Active, not recruiting
8 participants
Started: Aug 21, 2020 · Completed: Jul 19, 2026
5 conditions2 sponsors1 location
NCT04472910
GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma
NAActive, not recruiting
84 participants
Started: Aug 21, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors8 locations
NCT04707235
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study
N/AActive, not recruiting
2,093 participants
Started: Aug 21, 2020 · Completed: Aug 21, 2025
1 condition2 sponsors87 locations
NCT04542824
Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)
PHASE1/PHASE2Active, not recruiting
78 participants
Started: Aug 20, 2020 · Completed: Sep 30, 2027
6 conditions2 sponsors15 locations
NCT04141644
Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC
PHASE1Active, not recruiting
24 participants
Started: Aug 20, 2020 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT04388852
DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers
PHASE1Active, not recruiting
65 participants
Started: Aug 20, 2020 · Completed: Dec 31, 2026
10 conditions2 sponsors1 location
NCT04432857
AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
PHASE1Active, not recruiting
63 participants
Started: Aug 20, 2020 · Completed: Jan 30, 2025
5 conditions2 sponsors6 locations
NCT04340076
Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis
PHASE4Active, not recruiting
244 participants
Started: Aug 20, 2020 · Completed: Dec 31, 2025
2 conditions4 sponsors19 locations
NCT04404283
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
PHASE3Active, not recruiting
239 participants
Started: Aug 20, 2020 · Completed: Nov 18, 2025
1 condition1 sponsor185 locations
NCT04410406
Moxidectin for LF, Cote d'Ivoire (DOLF)
PHASE3Active, not recruiting
164 participants
Started: Aug 20, 2020 · Completed: Sep 1, 2024
1 condition3 sponsors1 location
NCT04989556
Technology-Enhanced Palliative Care for Advanced Cancer Patients
NAActive, not recruiting
119 participants
Started: Aug 20, 2020 · Completed: May 7, 2026
1 condition1 sponsor1 location
NCT04219696
Determining the Optimal Dose of Reactive Balance Training After Stroke
NAActive, not recruiting
36 participants
Started: Aug 20, 2020 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT04558138
RCT Implant Based Breast Reconstruction
NAActive, not recruiting
123 participants
Started: Aug 20, 2020 · Completed: Jan 5, 2026
1 condition2 sponsors1 location
NCT04476862
Cerliponase Alfa Observational Study in the US
N/AActive, not recruiting
35 participants
Started: Aug 19, 2020 · Completed: Aug 31, 2030
1 condition1 sponsor16 locations
NCT04149509
ACT NOW Longitudinal Study: Outcomes of Babies With Opioid Exposure Study
N/AActive, not recruiting
300 participants
Started: Aug 19, 2020 · Completed: Dec 31, 2026
1 condition2 sponsors6 locations
NCT04532177
Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery
EARLY_PHASE1Active, not recruiting
15 participants
Started: Aug 19, 2020 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT04461938
Characterization of Metabolic Changes in the Glioma Tumor Tissue Induced by Transient Fasting (ERGO3)
NAActive, not recruiting
30 participants
Started: Aug 19, 2020 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04464876
SATURN Transcatheter Mitral Valve Replacement for Functional Mitral Regurgitation
NAActive, not recruiting
20 participants
Started: Aug 19, 2020 · Completed: Dec 31, 2024
5 conditions1 sponsor3 locations
NCT04482894
Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS
PHASE2Active, not recruiting
105 participants
Started: Aug 19, 2020 · Completed: Apr 1, 2026
4 conditions1 sponsor1 location
NCT04331275
Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant
PHASE2Active, not recruiting
42 participants
Started: Aug 18, 2020 · Completed: Sep 30, 2028
2 conditions2 sponsors1 location
NCT04227899
LIFE-BTK Randomized Controlled Trial
NAActive, not recruiting
261 participants
Started: Aug 18, 2020 · Completed: Jul 31, 2027
1 condition1 sponsor50 locations
NCT04506567
Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC
PHASE1/PHASE2Active, not recruiting
60 participants
Started: Aug 18, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor2 locations
NCT04425070
A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma
PHASE1/PHASE2Active, not recruiting
56 participants
Started: Aug 18, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor13 locations
NCT04370054
Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults
PHASE3Active, not recruiting
77 participants
Started: Aug 18, 2020 · Completed: Oct 25, 2028
1 condition1 sponsor36 locations
NCT04456322
Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma
PHASE3Active, not recruiting
381 participants
Started: Aug 17, 2020 · Completed: May 11, 2027
1 condition1 sponsor1 location
NCT04263467
High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM)
NAActive, not recruiting
54 participants
Started: Aug 17, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04177940
Denosumab (DMAB) Discontinuation and Switching in Glucocorticoid-Induced Osteoporosis (GIOP): a Pilot Study
PHASE4Active, not recruiting
45 participants
Started: Aug 17, 2020 · Completed: Aug 31, 2025
1 condition4 sponsors1 location
NCT04419402
Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer
PHASE2Active, not recruiting
162 participants
Started: Aug 17, 2020 · Completed: Jan 1, 2025
1 condition5 sponsors15 locations
NCT04196972
Telementoring Intervention (ECHO) for the Transformation of Professional Engagement, Practice Efficiency, and Community Building Through Team Meetings in Diagnostic Imaging Clinicians
NAActive, not recruiting
36 participants
Started: Aug 16, 2020 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT04383951
Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis
NAActive, not recruiting
40 participants
Started: Aug 15, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04765943
Prognosis Impact of NSVTs After an AMI (TeVeO Study).
N/AActive, not recruiting
224 participants
Started: Aug 15, 2020 · Completed: Jun 30, 2025
5 conditions4 sponsors1 location
NCT04744883
Efficacy of Spinal Manipulation Therapy or Mindfulness-based Reduction Therapy on Patients With Chronic Low Back Pain
EARLY_PHASE1Active, not recruiting
140 participants
Started: Aug 15, 2020 · Completed: Jun 1, 2026
1 condition2 sponsors2 locations
NCT04543695
A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
PHASE2Active, not recruiting
255 participants
Started: Aug 15, 2020 · Completed: Jun 1, 2025
1 condition6 sponsors1 location
NCT04416568
Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
PHASE2Active, not recruiting
45 participants
Started: Aug 14, 2020 · Completed: Jun 30, 2026
7 conditions2 sponsors8 locations
NCT04504266
Perioperative Optimization With Enhanced Recovery
NAActive, not recruiting
368 participants
Started: Aug 14, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor1 location